{
    "root": "303d7311-f94f-31bb-e063-6294a90aa97b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "PROMETHAZINE HYDROCHLORIDE",
    "value": "20250313",
    "ingredients": [
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "METHYLCELLULOSE (100 CPS)",
            "code": "4GFU244C4J"
        },
        {
            "name": "PROMETHAZINE HYDROCHLORIDE",
            "code": "R61ZEH7I1I"
        }
    ],
    "indications": "promethazine hydrochloride tablets , usp useful : perennial seasonal allergic rhinitis . vasomotor rhinitis . allergic conjunctivitis due inhalant allergens foods . mild , uncomplicated allergic skin manifestations urticaria angioedema . amelioration allergic blood plasma . dermographism . anaphylactic , adjunctive therapy epinephrine standard measures , acute manifestations controlled . preoperative , postoperative , obstetric sedation . prevention control nausea vomiting associated certain types anesthesia surgery . therapy adjunctive meperidine analgesics control post-operative pain . sedation children adults , well relief apprehension production light sleep patient easily aroused . active prophylactic treatment motion sickness . antiemetic therapy postoperative patients .",
    "contraindications": "promethazine hydrochloride tablets , usp contraindicated children 2 years age ( - black box warning pediatric patients ) . promethazine hydrochloride tablets , usp oral . allergy average oral dose 25 mg taken retiring ; however , 12.5 mg may taken meals retiring , necessary . single 25 mg doses bedtime 6.25 mg 12.5 mg taken three times daily usually suffice . initiation treatment children adults , adjusted smallest amount adequate relieve symptoms . promethazine hydrochloride 25 mg doses control minor transfusion allergic nature . motion sickness average adult dose 25 mg taken twice daily . initial dose taken one-half one hour anticipated travel repeated 8 12 hours later , necessary . succeeding days travel , recommended 25 mg given arising evening meal . children , promethazine hydrochloride tablets , usp 12.5 mg 25 mg , twice daily , may administered . nausea vomiting antiemetics used vomiting unknown etiology children adolescents ( - pediatric patients ) . average effective dose promethazine hydrochloride tablets , usp active therapy nausea vomiting children adults 25 mg. 12.5 25 mg doses may repeated , necessary , 4 6 hour intervals . nausea vomiting children , usual dose 0.5 mg per pound body weight , dose adjusted age weight patient severity condition treated . prophylaxis nausea vomiting , surgery postoperative period , average dose 25 mg repeated 4 6 hour intervals , necessary . sedation product relieves apprehension induces quiet sleep patient easily aroused . 12.5 25 mg promethazine hydrochloride orally bedtime provide sedation children . adults usually require 25 50 mg nighttime , presurgical , obstetrical sedation . pre- postoperative promethazine hydrochloride tablets , usp 12.5 25 mg doses children 50 mg doses adults night surgery relieves apprehension produces quiet sleep . preoperative medication , children require doses 0.5 mg per pound body weight combination appropriately reduced dose narcotic barbiturate appropriate dose atropine-like . usual adult 50 mg promethazine hydrochloride tablets , usp appropriately reduced dose narcotic barbiturate required amount belladonna alkaloid . postoperative sedation adjunctive analgesics may obtained 12.5 25 mg children 25 50 mg doses adults . promethazine hydrochloride tablets , usp contraindicated children 2 years age .",
    "warningsAndPrecautions": "promethazine hydrochloride tablets , usp available follows : promethazine hydrochloride tablets , usp 25 mg supplied white colored , round shaped , flat face bevel edge tablets , debossed “ k 3 ” one side quadrisected side . ndc 43063-874-79 bottles 1 ndc 43063-874-02 bottles 2 ndc 43063-874-04 bottles 4 ndc 43063-874-05 bottles 5 ndc 43063-874-06 bottles 6 ndc 43063-874-10 bottles 10 ndc 43063-874-12 bottles 12 ndc 43063-874-15 bottles 15 ndc 43063-874-20 bottles 20 ndc 43063-874-30 bottles 30 ndc 43063-874-01 bottles 100 ndc 43063-874-95 bottles 1000 storeat 20° 25°c excursions permitted 15° 30°c ( 59° 86°f ) [ usp controlled room temperature ] . protectfrom light . dispensein tight , light-resistant container defined usp , child-resistant closure ( required ) .",
    "adverseReactions": "promethazine hydrochloride tablets , usp contraindicated pediatric patients less two years age . promethazine hydrochloride tablets , usp contraindicated comatose states , individuals known hypersensitive idiosyncratic reaction promethazine phenothiazines . antihistamines contraindicated treatment lower respiratory tract symptoms including asthma .",
    "indications_original": "Promethazine hydrochloride tablets, USP are useful for:\n                  Perennial and seasonal allergic rhinitis.\n                  Vasomotor rhinitis.\n                  Allergic conjunctivitis due to inhalant allergens and foods.\n                  Mild, uncomplicated allergic skin manifestations of urticaria and angioedema.\n                  Amelioration of allergic reactions to blood or plasma.\n                  Dermographism.\n                  Anaphylactic reactions, as adjunctive therapy to epinephrine and other standard measures, after the acute manifestations have been controlled.\n                  Preoperative, postoperative, or obstetric sedation.\n                  Prevention and control of nausea and vomiting associated with certain types of\n                  anesthesia and surgery.\n                  Therapy adjunctive to meperidine or other analgesics for control of post-operative pain.\n                  Sedation in both children and adults, as well as relief of apprehension and production of light sleep from which the patient can be easily aroused.\n                  Active and prophylactic treatment of motion sickness.\n                  Antiemetic therapy in postoperative patients.",
    "contraindications_original": "Promethazine hydrochloride tablets, USP are contraindicated for children under 2 years of age(see\n \n  \n                        WARNINGS - Black Box Warning\n                     and\n \n  \n                        Use in Pediatric Patients\n                     ).\n\n \n                  Promethazine hydrochloride tablets, USP are for oral administration only.\n                  \n                     Allergy\n                  \n                  The average oral dose is 25 mg taken before retiring; however, 12.5 mg may be taken before meals and on retiring, if necessary. Single 25 mg doses at bedtime or 6.25 mg to 12.5 mg taken three times daily will usually suffice. After initiation of treatment in children or adults, dosage should be adjusted to the smallest amount adequate to relieve symptoms. The administration of promethazine hydrochloride in 25 mg doses will control minor transfusion reactions of an allergic nature.\n                  \n                     Motion Sickness\n                  \n                  The average adult dose is 25 mg taken twice daily. The initial dose should be taken one-half to one hour before anticipated travel and be repeated 8 to 12 hours later, if necessary. On succeeding days of travel, it is recommended that 25 mg be given on arising and again before the evening meal. For children, promethazine hydrochloride tablets, USP 12.5 mg to 25 mg, twice daily, may be administered.\n                  \n                     Nausea and Vomiting\n                  \n                  Antiemetics should not be used in vomiting of unknown etiology in children and adolescents (see\n \n  \n                        WARNINGS - Use in Pediatric Patients\n                     ).\n\n \n                  The average effective dose of promethazine hydrochloride tablets, USP for the active therapy of nausea and vomiting in children or adults is 25 mg. 12.5 to 25 mg doses may be repeated, as necessary, at 4 to 6 hour intervals.\n                  For nausea and vomiting in children, the usual dose is 0.5 mg per pound of body weight, and the dose should be adjusted to the age and weight of the patient and the severity of the condition being treated.\n                  For prophylaxis of nausea and vomiting, as during surgery and the postoperative period, the average dose is 25 mg repeated at 4 to 6 hour intervals, as necessary.\n                  \n                     Sedation\n                  \n                  This product relieves apprehension and induces a quiet sleep from which the patient can be easily aroused. Administration of 12.5 to 25 mg promethazine hydrochloride orally at bedtime will provide sedation in children. Adults usually require 25 to 50 mg for nighttime, presurgical, or obstetrical sedation.\n                  \n                     Pre- and Postoperative Use\n                  \n                  Promethazine hydrochloride tablets, USP in 12.5 to 25 mg doses for children and 50 mg doses for adults the night before surgery relieves apprehension and produces a quiet sleep.\n                  For preoperative medication, children require doses of 0.5 mg per pound of body weight in combination with an appropriately reduced dose of narcotic or barbiturate and the appropriate dose of an atropine-like drug. Usual adult dosage is 50 mg promethazine hydrochloride tablets, USP with an appropriately reduced dose of narcotic or barbiturate and the required amount of a belladonna alkaloid.\n                  Postoperative sedation and adjunctive use with analgesics may be obtained by the administration of 12.5 to 25 mg in children and 25 to 50 mg doses in adults.\n                  Promethazine hydrochloride tablets, USP are contraindicated for children under 2 years of age.",
    "warningsAndPrecautions_original": "Promethazine hydrochloride tablets, USP are available as follows:\n                  Promethazine hydrochloride tablets, USP 25 mg are supplied as white colored, round shaped, flat face bevel edge tablets, debossed “K 3” on one side and quadrisected on the other side.\n                  NDC 43063-874-79 Bottles of 1\n                  NDC 43063-874-02 Bottles of 2\n                  NDC 43063-874-04 Bottles of 4\n                  NDC 43063-874-05 Bottles of 5\n                  NDC 43063-874-06 Bottles of 6\n                  NDC 43063-874-10 Bottles of 10\n                  NDC 43063-874-12 Bottles of 12\n                  NDC 43063-874-15 Bottles of 15\n                  NDC 43063-874-20 Bottles of 20\n                  NDC 43063-874-30 Bottles of 30\n                  NDC 43063-874-01 Bottles of 100\n                  NDC 43063-874-95 Bottles of 1000\n                  \n                     Storeat 20° to 25°C with excursions permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature].\n\n \n                  \n                     Protectfrom light.\n\n \n                  \n                     Dispensein a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).",
    "adverseReactions_original": "Promethazine hydrochloride tablets, USP are contraindicated for use in pediatric patients less than two years of age.\n                  Promethazine hydrochloride tablets, USP are contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines.\n                  Antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms including asthma."
}